Seeyond Regeneron Pharmaceuticals, Inc. Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Seeyond holds 5,470 shares of REGN stock, worth $5.75 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

5,470

Previous 4,597 18.99%

Holding current value

$5.75 Million

Previous $3.17 Million 24.64%

% of portfolio

0.38%

Previous 0.38%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $616,241 - $669,058	873 Added 18.99%	5,470 $3.95 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $328,884 - $415,035	-573 Reduced 11.08%	4,597 $3.17 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $1.05 Million - $1.42 Million	-1,921 Reduced 27.09%	5,170 $3.06 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.59 Million - $1.86 Million	-2,667 Reduced 27.33%	7,091 $4.95 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1 Million - $1.24 Million	-1,846 Reduced 15.91%	9,758 $6.16 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $812,826 - $964,239	-1,416 Reduced 10.88%	11,604 $7.02 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $15,602 - $18,431	33 Added 0.25%	13,020 $7.27 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $2.96 Million - $3.63 Million	6,624 Added 104.1%	12,987 $6.14 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.3 Million - $1.65 Million	2,717 Added 74.52%	6,363 $3.07 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $159,067 - $192,197	-292 Reduced 7.41%	3,646 $2.04 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $140,102 - $182,873	284 Added 7.77%	3,938 $2.46 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $224,904 - $330,773	669 Added 22.41%	3,654 $89,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $472,600 - $649,103	-1,724 Reduced 36.61%	2,985 $1.12 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $295,336 - $343,861	-1,080 Reduced 18.66%	4,709 $1.31 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $58,122 - $80,475	-194 Reduced 3.24%	5,789 $1.81 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.19 Million - $1.41 Million	3,201 Added 115.06%	5,983 $2.46 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $934,251 - $1.12 Million	2,782 New	2,782 $1.04 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account